PD-L1 expression associated with better response to EGFR tyrosine kinase inhibitors

Benzer Materyaller

• BRIEF REPORT: Compound EGFR mutations and response to EGFR tyrosine kinase inhibitors
  Yazar:: Kobayashi, Susumu, ve diğerleri
  Baskı/Yayın Bilgisi: (2013)
• Update on third-generation EGFR tyrosine kinase inhibitors
  Yazar:: Gray, Jhanelle, ve diğerleri
  Baskı/Yayın Bilgisi: (2014)
• EGFR Mutation Heterogeneity and the Mixed Response to EGFR Tyrosine Kinase Inhibitors of Lung Adenocarcinomas
  Yazar:: Chen, Zhi-Yong, ve diğerleri
  Baskı/Yayın Bilgisi: (2012)
• Stressing the need to overcome EGFR tyrosine kinase inhibitor resistance
  Yazar:: Toulabi, Leila, ve diğerleri
  Baskı/Yayın Bilgisi: (2018)
• egfr tyrosine kinase inhibitors in lung cancer: make no assumptions
  Yazar:: Melosky†, B.
  Baskı/Yayın Bilgisi: (2012)